3835 related articles for article (PubMed ID: 32132184)
21. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.
Lim H; Baek A; Kim J; Kim MS; Liu J; Nam KY; Yoon J; No KT
Sci Rep; 2020 Oct; 10(1):16862. PubMed ID: 33033344
[TBL] [Abstract][Full Text] [Related]
22. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2.
Verkhivker G
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
Tai W; He L; Zhang X; Pu J; Voronin D; Jiang S; Zhou Y; Du L
Cell Mol Immunol; 2020 Jun; 17(6):613-620. PubMed ID: 32203189
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.
Tan HW; Xu YM; Lau ATY
Rev Med Virol; 2020 Sep; 30(5):e2122. PubMed ID: 32602627
[TBL] [Abstract][Full Text] [Related]
25. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
Chi X; Yan R; Zhang J; Zhang G; Zhang Y; Hao M; Zhang Z; Fan P; Dong Y; Yang Y; Chen Z; Guo Y; Zhang J; Li Y; Song X; Chen Y; Xia L; Fu L; Hou L; Xu J; Yu C; Li J; Zhou Q; Chen W
Science; 2020 Aug; 369(6504):650-655. PubMed ID: 32571838
[TBL] [Abstract][Full Text] [Related]
26. Structural models of human ACE2 variants with SARS-CoV-2 Spike protein for structure-based drug design.
Sorokina M; M C Teixeira J; Barrera-Vilarmau S; Paschke R; Papasotiriou I; Rodrigues JPGLM; Kastritis PL
Sci Data; 2020 Sep; 7(1):309. PubMed ID: 32938937
[TBL] [Abstract][Full Text] [Related]
27. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
[TBL] [Abstract][Full Text] [Related]
28. Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.
Su C; He J; Han P; Bai B; Li D; Cao J; Tian M; Hu Y; Zheng A; Niu S; Chen Q; Rong X; Zhang Y; Li W; Qi J; Zhao X; Yang M; Wang Q; Gao GF
J Virol; 2022 Sep; 96(17):e0081422. PubMed ID: 36000849
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2.
Zheng Z; Monteil VM; Maurer-Stroh S; Yew CW; Leong C; Mohd-Ismail NK; Cheyyatraivendran Arularasu S; Chow VTK; Lin RTP; Mirazimi A; Hong W; Tan YJ
Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700671
[TBL] [Abstract][Full Text] [Related]
30. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor.
Yang J; Petitjean SJL; Koehler M; Zhang Q; Dumitru AC; Chen W; Derclaye S; Vincent SP; Soumillion P; Alsteens D
Nat Commun; 2020 Sep; 11(1):4541. PubMed ID: 32917884
[TBL] [Abstract][Full Text] [Related]
31. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection.
Luan J; Lu Y; Jin X; Zhang L
Biochem Biophys Res Commun; 2020 May; 526(1):165-169. PubMed ID: 32201080
[TBL] [Abstract][Full Text] [Related]
32. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.
Wrapp D; Wang N; Corbett KS; Goldsmith JA; Hsieh CL; Abiona O; Graham BS; McLellan JS
Science; 2020 Mar; 367(6483):1260-1263. PubMed ID: 32075877
[TBL] [Abstract][Full Text] [Related]
33. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections.
Li F
J Virol; 2008 Jul; 82(14):6984-91. PubMed ID: 18448527
[TBL] [Abstract][Full Text] [Related]
34. Design of an engineered ACE2 as a novel therapeutics against COVID-19.
Payandeh Z; Rahbar MR; Jahangiri A; Hashemi ZS; Zakeri A; Jafarisani M; Rasaee MJ; Khalili S
J Theor Biol; 2020 Nov; 505():110425. PubMed ID: 32735992
[TBL] [Abstract][Full Text] [Related]
35. ACE2, B
Zhang Y; Yan R; Zhou Q
Curr Opin Struct Biol; 2022 Jun; 74():102388. PubMed ID: 35584583
[TBL] [Abstract][Full Text] [Related]
36. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
Walls AC; Park YJ; Tortorici MA; Wall A; McGuire AT; Veesler D
Cell; 2020 Apr; 181(2):281-292.e6. PubMed ID: 32155444
[TBL] [Abstract][Full Text] [Related]
37. Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.
Wu T; Zhang H; Hu E; Ma J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):591-597. PubMed ID: 32879112
[TBL] [Abstract][Full Text] [Related]
38. Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.
Yurkovetskiy L; Wang X; Pascal KE; Tomkins-Tinch C; Nyalile TP; Wang Y; Baum A; Diehl WE; Dauphin A; Carbone C; Veinotte K; Egri SB; Schaffner SF; Lemieux JE; Munro JB; Rafique A; Barve A; Sabeti PC; Kyratsous CA; Dudkina NV; Shen K; Luban J
Cell; 2020 Oct; 183(3):739-751.e8. PubMed ID: 32991842
[TBL] [Abstract][Full Text] [Related]
39. Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates.
Alazmi M; Motwalli O
J Mol Model; 2020 Nov; 26(12):338. PubMed ID: 33175236
[TBL] [Abstract][Full Text] [Related]
40. Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV?
Nguyen HL; Lan PD; Thai NQ; Nissley DA; O'Brien EP; Li MS
J Phys Chem B; 2020 Aug; 124(34):7336-7347. PubMed ID: 32790406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
